| GBM | Glioblastoma multiforme |
| BBB | Blood–brain barrier |
| EC | Endothelial cells |
| DCE-MR | Dynamic contrast-enhanced magnetic resonance |
| CSC | Cancer stem cells |
| miRNAs | microRNAs |
| lncRNAs | Long non-coding RNAs |
| VEGF | Vascular endothelial growth factor |
| VM | Vascular mimicry |
| PD-L1 | Programmed death-ligand 1 |
| TGF-β | Tumor growth factor β |
| CLDN 4 | Claudin-4 |
| TME | Tumor microenvironment |
| TK | Tyrosine kinase |
| EGFR | Epidermal growth factor receptor |
| PDGFR | Platelet-derived growth factor |
| CAR-T | Chimeric antigen receptor T-cells |
| PDHA | Pyruvate dehydrogenase alpha |
| OGDH | Alpha ketoglutarate dehydrogenase |
| Hsp90 | Heat shock protein 1 |
| TRAP1 | TNF receptor associated protein 1 |
| IDH | Isocitrate dehydrogenase |
| 2-HG | d-2-hydroxyglutarate |
| PFS | Progression free survival |
| OS | Overall survival |